Information Provided By:
Fly News Breaks for January 19, 2018
VNDA
Jan 19, 2018 | 08:37 EDT
Seaport Global analyst Corey David initiated Vanda with a Buy and $20 price target. David said the long-term cash-flows from Fanapt and Hetlioz alone should be able to justify the current valuation, and potential upside would come with success on tradipitant on either one of its two indications being studied in the clinic.
News For VNDA From the Last 2 Days
There are no results for your query VNDA